Pharmaceutical composition for treating atherosclerosis and application

A technology for atherosclerosis and composition, applied in the field of medicine, can solve problems such as unsatisfactory effects, and achieve the effects of natural non-toxic long-term use, treatment of atherosclerosis, and suitable for long-term use

Inactive Publication Date: 2016-10-12
XINXIANG MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

General prevention is mainly based on reasonable diet, physica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating atherosclerosis and application
  • Pharmaceutical composition for treating atherosclerosis and application
  • Pharmaceutical composition for treating atherosclerosis and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition is prepared from the following raw materials: 101 parts of vervescoside, 6 parts of Angelica A and 9 parts of aristolochic acid.

Embodiment 2

[0036] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition is prepared by comprising the following raw materials: 0.5 parts of vervescoside, 105 parts of Angelica A and 102 parts of aristolochic acid.

Embodiment 3

[0038] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition is prepared from the following raw materials: 103 parts of verbascoside, 7 parts of Angelica A, and 103 parts of aristolochic acid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to a pharmaceutical composition for treating atherosclerosis and its application; the pharmaceutical composition is prepared from the following raw materials: acteocoside, angelica root A, and aristolochic acid; it has stable quality control, is safe and effective, and is natural The advantages of being non-toxic and suitable for long-term use.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition and application for treating atherosclerosis. Background technique [0002] Atherosclerosis is a kind of arteriosclerosis, which mainly occurs in the intima of large and medium arteries, and yellow atherosclerotic plaques containing cholesterol and fat-like substances appear, which are mostly caused by fat metabolism disorders and neurovascular dysfunction. Often lead to thrombosis, blood supply disorders and so on. The incidence of atherosclerosis is more common in men over the age of 40 and postmenopausal women. The disease is often accompanied by hypertension, hypercholesterolemia or diabetes. Atherosclerosis is a common disease, frequently-occurring disease, one of the diseases with high mortality and disability rate, which seriously endangers the life and health of human beings. . [0003] At present, there is no better drug for ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7048A61P9/10A61K31/36A61K31/37
CPCA61K31/36A61K31/37A61K31/7048
Inventor 李鹏贾岩龙薛金涛马丽娟朱茉莉赵繁荣牛秉轩万光瑞
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap